Physician profile
Jon Michael Gerry
NPI 1225353824
$5,356.63
in general payments reported to CMS, 2019-2025
9 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.54 · 2022: $901 · 2023: $2,077 · 2024: $2,142 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,513 · Education: $1,137 · Food and Beverage: $706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,512.61 |
| Education | $1,137.13 |
| Food and Beverage | $706.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,901.44 | 2022-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $1,796.90 | 2023 | Ligasure, Signia |
| Boston Scientific Corporation | $147.62 | 2024 | |
| Genentech USA, INC. | $140.77 | 2022 | |
| Nestle Healthcare Nutrition INC. | $116.12 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $99.54 | 2019 | |
| Intera Oncology, INC | $90.82 | 2023 | Intera 3000 Implantable Pump |
| Davol INC. | $41.55 | 2022 | |
| Aimmune Therapeutics, INC. | $21.87 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Gerry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.